Displaying 37 - 44 of 44

Display:

12 24 48

Immune-Mediated and Cholestatic Diseases

7

CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis - EASL Congress 2024

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Immune-Mediated and Cholestatic Diseases

5

GSK: Holistic patient care in PBC: moving beyond ALP to QoL - ILC 2022

View

Viral Hepatitis

2

GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021

View

Viral Hepatitis

2

GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021

View

Displaying 37 - 44 of 44

Display:

12 24 48